India: The Indian Pharmacopoeia Commission (IPC) has recently issued a drug safety alert on the common painkiller Meftal. The IPC is an autonomous institution of the Ministry of Health that sets standards for all drugs that are manufactured, sold, and consumed in India. The IPC has advised consumers and healthcare professionals (HCPs) to exercise caution […]
UK: Findings from a recent longitudinal study published in The Lancet Psychiatry suggest that greater body dissatisfaction in late childhood is an important risk factor for depression during adolescence, irrespective of the child’s body mass index (BMI). “Body dissatisfaction at age 11 is linked to increased risk of depression by age 14,” UCL researchers report. […]
A recent study has shed new light on the potential impact of early pharmacological interventions on scoliosis progression in individuals with Type II spinal muscular atrophy (SMA). Scoliosis, affecting up to 90% of Type II SMA cases, poses a significant challenge, and while treatments have shown improvements in motor function, their effect on scoliosis remains […]
Dapagliflozin may improve symptoms in patients with HFrEF with limited impact on exercise capacity suggests a new study published in the Circulation. Sodium-glucose cotransporter 2 inhibitors reduce the risk of worsening heart failure (HF) and cardiovascular death in patients with HF irrespective of left ventricular ejection fraction. It is important to determine whether therapies for […]
USA: The researchers at the Smidt Heart Institute at Cedars-Sinai and colleagues at two other institutions have developed an artificial intelligence (AI) tool that accurately predicts how patients would fare after surgeries and procedures. The results, published in The Lancet Digital Health, include data from patients from three healthcare systems: Cedars-Sinai, Stanford University and Columbia […]
New Delhi: Granting the local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved drug major Lupin’s Rifapentine dispersible Tablets 150mg for already approved indication with the condition of conducting a Phase IV Clinical study. This came after the firm presented their proposal for a […]
Diet rich in Fresh vegetables has potential benefit of improving eGFR among elderly suggests a new study published in the BMC Nephrology. This study aimed to investigate the relationship between the consumption of fresh and salt-preserved vegetables and the estimated glomerular filtration rate (eGFR), which requires further research. The prevalence of chronic kidney disease (CKD) […]
New Delhi: Rejecting the proposal for clinical trial and bioequivalence (BE) study waiver presented by drug major Cipla, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the firm to conduct the BE study of the fixed-dose combination Formoterol Fumarate Dihydrate plus Glycopyrronium inhaler with innovator product as […]
Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult patients. The Joint Task Force is a partnership between the American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, […]
Bayer has announced that Shweta Rai will take over as Managing Director of Bayer Zydus Pharma Private Limited and Country Division Head (CDH) for Bayer’s Pharmaceuticals Business in South Asia effective, January 1, 2024. Manoj Saxena will move out of his present role to take on the role of CDH for Bayer’s Pharmaceuticals Division and […]